Bloodcoagulation. Modern state
https://doi.org/10.30629/0023-2149-2024-102-4-285-290
Abstract
The article provides information on historical issues — the discovery of blood clotting factors, anticoagulant and thrombolytic therapy, on modern understanding, diagnosis and treatment of arterial and venous thrombosis, atherothrombosis, venous thromboembolism, intravascular microthrombosis syndrome, hemophilias and immunothrombosis. Assumptions about the development of atherosclerosis are presented.
About the Author
I. N. Bokarev
Igor N. Bokarev — Dr. of Sci. (Med.), Professor, President of the Russian Association on Thrombosis, Hemostasis and Vascular Pathology named after A. Schmidt–B. Kudryashov
Russian Federation
Russian Federation
References
1. Owen Charles. A History of blood coagulation. Rochester. Minnesota. 2001.
2. Schmidt A. Ueber den Faserstoff und die Ursachen seiner Gerinnung. Reichert-DuBois-Reymond”s. Arch. Anat. Physiol.1861:545–587
3. Bizzozero“s new corpuscle. Lanzet. 1882;1:446.
4. Arthus M., Pages C. Nouvelle theorie chimique de la coagulation du sang. Arch. Physiol. 1890;2:739–746.
5. Kudryashov B.A. Problems of Bloodcoagulation and Thrombosis. M, 1960. (In Russian).
6. Laboratory methods of bloodclotting investigation. Recomendations. RATHVP and RAMLD. Moscow, 2016 (In Russian).
7. Bokarev I.N., Popova L.V., Kozlova T.V. Thrombosis and Antithrombotic therapy in clinical practice. Moscow, MIA, 2009. (In Russian).
8. Ross R. Atherosclerosis-an infl ammatory disease. N. Engl. J. Med. 1999;340(2):115–126.
9. Moreno P. Pathophysiology of atherotrombos. In athrothrombosis: the global approach for global disease. Hightlights monograf from an international expert meeting on Atherothrombosis. 1998;26–27:2–4.
10. Bokarev I.N., Popova L.V. Venous thromboembolism and pulmonary thrombo embolism. Moscow, MIA, 2005. (In Russian).
11. Bergquist D., Lindblad B. A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. British J. Surg. 1985:105–108.
12. Stein P.D. Henry J.W. Prevalence of acute pulmonary embolism amon patients in a general hospital and at autopsy. Chest. 1995:978–981.
13. Virchow R. Phlebose und thrombose in gefasssystem. Gesammelte Abhandlungen zur wissenschafl ihen Medizin. Frankfurt. 1856.
14. Rosendal F.R. Testing for thrombophilia: is it ever useful? В кн: Международный кoнгресс тромбозы, гемостаз и патология сосудов. Современные подходы к диагностике и лечению. М., 2014:88. [In book: International Congress-thrombosis, haemostsis and vascular pathology. Modern approach to diagnosis and treatment. Moscow, 2014:88. (In Russian)].
15. Bokarev I.N., Popova L.V. Savin A.A. DIC-syndrome and constant intravascular microbloodcoagulation. RATBAVP. Moscow, 2016. (In Russian).
16. Popova L.V., Kondratyeva T.B., Kozlova T.V., Bokarev I.N. Oral anticoagulants. Second edition. Moscow, MIA, 2021. (In Russian).
17. Tillett W.S., Garner R.L. The fi brinolytic activity of hemolytic streptococci. J. Exper. Med. 1933;68:485–502.
18. Tillett W.S. Sharry S. Te eff ect in patients of streptococcal fi b rinolysin (streptokinase) on ibrinous,purulent and sanguinous pleural exudation. J. Сlin. Invest.1949;28:173–190.
19. Fletcher A.P. Alkersig N. Sherry S. Treatment of patients suff ering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans. Assoc. Amer. Physician. 1958;71:287–296.
20. Andreenko G.V. Fibrinolysis. M., 1967. (In Russian).
21. Chasov E.I., Lakin K.M. Anticoagulants and Thrombolytics. M., Medicine, 1977. (In Russian).
22. Bokarev I.N., Pavlov A.V., Yankin V.V., Chausovsky G.M. Fibrinolysin and streptokynases infl uence on myo cardial infarction. Klinicheskaya meditsina. 1991;11:110–113. (In Russian)]
23. Medvedev A.P., SobolevYu. A., Nemirova C.V. Stratedgy of pulmonary emboly treatment. In book: International congress on thrombosis, hemostasis and vascular pathology. Modern approaches to diagnosis and treatment. Moscow, 2014:79. (In Russian).
24. Medvedev A.P. (editor). Recommendation. Diadnosis, treatment and prevention of venous thrombosis and pulmonary embolism. M., 2016. (In Russian).
25. Hally K., Fauteux-Daniel S., Hamzeh-Cognasse H., Larsen P., Cognasse F. Revisiting platelets and toll-like receptors (TLRs): At the interface of vascular immunity and thrombosis. Int. J. Mol .Sci. 2020;21(17):6150. DOI: 10.3390/ijms21176150
26. Takei H., Araki A., Watanabe H., Ichinose A., Sendo F. Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes diff erent from typical apoptosis or necrosis. J. Leukoc. Biol. 1996;59(2):229–40. DOI: 10.1002/jlb.59.2.229
27. Brinkmann V., Reichard U., Goosmann Ch. et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-1535. DOI: 10.1126/science.1092385
28. Noubouossie D.F., Whelihan M.F., Yu Y.-B. et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood. 2017;129(08):1021–1029.
29. Engelmann B., Massberg S. Thrombosis as an intravascular eff ector of innate immunity. Nat. Rev. Immunol. 2013;13(1):34–45. DOI: 10.1038/nri3345
30. Wienkamp A.-K., Erpenbeck L. Rossaint J. Platelets in the NETworks interweaving infl ammation and thrombosis. Frontiers in Immunology. DOI: 10.3389/fi mmu.2022.953129
Review
For citations:
Bokarev I.N. Bloodcoagulation. Modern state. Clinical Medicine (Russian Journal). 2024;102(4):285-290. (In Russ.) https://doi.org/10.30629/0023-2149-2024-102-4-285-290
Views:
417
Email this article 